PRDM5
PR domain zinc finger protein 5
Also known as: PFM2, PRDM5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NQX1
- Gene
- PRDM5
- Ensembl
- ENSG00000138738
- Chromosome
- 4
- Canonical length
- 630 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli,Nuclear bodies
OverviewNCBI Gene
The protein encoded by this gene is a transcription factor of the PR-domain protein family. It contains a PR-domain and multiple zinc finger motifs. Transcription factors of the PR-domain family are known to be involved in cell differentiation and tumorigenesis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
630 residues, UniProt reviewed canonical sequence.
>Q9NQX1|PRDM5
1 MLGMYVPDRF SLKSSRVQDG MGLYTARRVR KGEKFGPFAG EKRMPEDLDE NMDYRLMWEV
61 RGSKGEVLYI LDATNPRHSN WLRFVHEAPS QEQKNLAAIQ EGENIFYLAV EDIETDTELL
121 IGYLDSDMEA EEEEQQIMTV IKEGEVENSR RQSTAGRKDR LGCKEDYACP QCESSFTSED
181 ILAEHLQTLH QKPTEEKEFK CKNCGKKFPV KQALQRHVLQ CTAKSSLKES SRSFQCSVCN
241 SSFSSASSFE QHQETCRGDA RFVCKADSCG KRLKSKDALK RHQENVHTGD PKKKLICSVC
301 NKKCSSASSL QEHRKIHEIF DCQECMKKFI SANQLKRHMI THSEKRPYNC EICNKSFKRL
361 DQVGAHKVIH SEDKPYKCKL CGKGFAHRNV YKNHKKTHSE ERPFQCEECK ALFRTPFSLQ
421 RHLLIHNSER TFKCHHCDAT FKRKDTLNVH VQVVHERHKK YRCELCNKAF VTPSVLRSHK
481 KTHTGEKEKI CPYCGQKFAS SGTLRVHIRS HTGERPYQCP YCEKGFSKND GLKMHIRTHT
541 REKPYKCSEC SKAFSQKRGL DEHKRTHTGE KPFQCDVCDL AFSLKKMLIR HKMTHNPNRP
601 LAECQFCHKK FTRNDYLKVH MDNIHGVADSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRDM5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 8.1 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 8.1 nTPM
- ovary: 7.8 nTPM
- endometrium: 5.6 nTPM
- thyroid gland: 5.4 nTPM
- cervix: 5.2 nTPM
- fallopian tube: 4.7 nTPM
Single-cell type
- podocytes: 319 nCPM
- choroid plexus epithelial cells: 316 nCPM
- pituicytes/fscs: 230 nCPM
- gonadotrophs: 185 nCPM
- neutrophils: 182 nCPM
- ependymal cells: 178 nCPM
Immune cell
- eosinophil: 7.5 nTPM
- neutrophil: 5.4 nTPM
- naive CD8 T-cell: 0.2 nTPM
- basophil: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- spinal cord: 14 nTPM
- white matter: 13 nTPM
- midbrain: 13 nTPM
- choroid plexus: 13 nTPM
- medulla oblongata: 13 nTPM
- cerebellum: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRDM5.
Disease | AllUniProt
Conditions PRDM5 is implicated in, by any mechanism.
- Brittle cornea syndrome 2 (BCS2) MIM:614170
Disease | GeneticClinVar
58 pathogenic / likely-pathogenic of 853 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Brittle cornea syndrome 2
- Cardiovascular phenotype
- Ehlers-Danlos syndrome
- PRDM5-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.7
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to leukemia inhibitory factor
- chromatin organization
- methylation
- mitotic cell cycle
- negative regulation of DNA-templated transcription
- negative regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase II
- regulation of extracellular matrix organization
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription factor binding
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- methyltransferase activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- transcription cis-regulatory region binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SET domain
- Zinc finger C2H2-type
- Zinc finger C2H2 superfamily
- SET domain superfamily
- Zinc finger PRDM4/PRDM1/PRDM14-like
- Zinc finger, C2H2 type
- Zinc-finger of C2H2 type
- C2H2-type zinc finger
- PR domain zinc finger protein 2, PR domain
- PR-domain zinc finger protein PRDM5-like
- PRDM5, PR/SET domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRDM5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRDM5 as an antibody target. Whether an autoantibody or antibody against PRDM5 could matter depends on whether native PRDM5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRDM5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRDM5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...